Taking the Embarrassment Out of Health Problems
We humans seem to have a nearly universal need to avoid embarrassment. It could be something as simple as mispronouncing a word or tripping as you walk along a crowded sidewalk. No matter the blunder, our response is instinctive: Hide, hope no one noticed and move on. But what happens when what you are embarrassed about is related to your health? There are some aspects of your body and how it functions that you'd really rather not talk about—even with a doctor. But sharing potentially embarrassing symptoms with your physicians may be the only way for them to accurately diagnose and treat you. Chances are specialists have heard it—and seen it—all before and know how to help.
Women’s Health Research at Yale to Fund Four New Studies
With seed money through this year’s Pilot Project Program – including the second-ever Naratil Pioneer Award recipient for research on the verge of a significant breakthrough – the researchers aim to answer questions vital to improving women’s health.
Chair of Biomedical Engineering elected to Institute of Medicine
Mark Saltzman, PhD, Goizueta Foundation Professor and chair of Biomedical Engineering, has been elected to the Institute of Medicine (IOM) of the National Academies, one of the highest honors in the fields of medicine and health. Election to the IOM recognizes excellence and professional achievement in a field relevant to the Institute’s mission.
Experts Call for Refined Treatment Paradigm in Urothelial Cancer
Treatments for metastatic urothelial cancer are expanding due to the number of immunotherapies available to patients and physicians, but the paradigm for patient treatment needs to be refined according to Dr. Daniel P. Petrylak.Source: Cure Today
FDA Approves Novel Drug Enfortumab Vedotin for Urothelial Cancer
The US Food and Drug Administration has granted accelerated approval to the novel agent enfortumab vedotin (PADCEV, Astellas) for the treatment of locally advanced or metastatic urothelial cancer that has progressed on chemotherapy and immunotherapy.Source: Medscape
Adam Hittelman, MD, PhD appointed Section Chief of Pediatric Urology and Vice Chair of Urology for Faculty Affairs and Administration
Adam Hittelman, MD, PhD, has been appointed Section Chief of Pediatric Urology for Yale New Haven Children’s Hospital and Yale Urology and as Vice Chair of Urology for Faculty Affairs and Administration.
John Onofrey, PhD joins Yale Urology as Assistant Professor
John Onofrey, PhD has been appointed an Assistant Professor of Urology and of Radiology & Biomedical Imaging, effective July 1, 2019. Dr. Onofrey begins this dual appointment after serving as Postdoctoral Associate and Associate Research Scientist in the Department of Radiology & Biomedical Imaging for the last six years.
Yale Pediatric Urology Ranked 16 in Nation by U.S. News & World Report
In today’s release of the U.S. News and World Report rankings of the 2019 Best Children’s Hospitals rankings, Yale New Haven Children’s Hospital (YNHCH) ranked #16 in the nation for urology services. The ranking reflects Yale Urology’s experience, safety, and advanced patient care for our pediatric patients.
New urologists now practicing at L+M
Yale Urology recently welcomed Joseph Renzulli, MD, and Joseph Brito, MD, to its new practice location at L+M Hospital. In addition to general adult urology care for both men and women, Dr. Renzulli and Dr. Brito provide care for patients with urologic cancers in coordination with the Smilow Cancer Hospital in Waterford and Smilow Cancer Hospital’s Prostate and Urologic Cancers Program.